Cats differ from other species in their cytokine and antioxidant enzyme response when developing obesity

Obesity

Volumn 21, Issue 9, 2013, Pages

  Hoenig, Margarethe ^a   Pach, Nicole ^a   Thomaseth, Karl ^b   Le, Anh ^c   Schaeffer, David ^a   Ferguson, Duncan C ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b CNR   (Italy)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CATALASE; GLUTATHIONE PEROXIDASE; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; LEPTIN; PROINSULIN; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL CAT; FAT MASS; FEMALE; GLUCOSE TRANSPORT; INFLAMMATION; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID STORAGE; LONGITUDINAL STUDY; MALE; NONHUMAN; OBESITY; OXIDATIVE STRESS; SEX RATIO; SPECIES DIFFERENCE; THERMOGENESIS; WEIGHT GAIN;

ADIPOKINES; ADIPOSE TISSUE; ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY COMPOSITION; CATALASE; CATS; CYTOKINES; ENERGY INTAKE; FEMALE; GLUTATHIONE PEROXIDASE; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; OBESITY; OXIDATIVE STRESS; SUBCUTANEOUS FAT; SUPEROXIDE DISMUTASE; THERMOGENESIS; WEIGHT GAIN;

EID: 84884902428     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20306     Document Type: Article

References (40)

1. Bastard JP, Maachi M, Van Nhieu JT, et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002; 87: 2084-2089.
2. Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17: 4-12.
3. Shoelson SE, Lee J, Goldfine AB,. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-1801.
4. Harle P, Straub RH,. Leptin is a link between adipose tissue and inflammation. Ann N Y Acad Sci 2006; 1069: 454-462.
5. Hoenig M, Thomaseth K, Waldron M, Ferguson DC,. Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss. Am J Physiol Regul Integr Comp Physiol 2007; 292: R227-R234.
6. Hoenig M, Jordan, ET, Glushka, J, et al. Effect of macronutrients, age, and obesity on 6 and 24-hour post-prandial glucose metabolism in cats. Am J Physiol Regul Integr Comp Physiol 2011; 301: R1798-R1807.
7. Brennan AM, Mantzoros CS,. Leptin and adiponectin: their role in diabetes. Curr Diab Rep 2007; 7: 1-2.
8. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI,. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394: 897-901.
9. Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A 2001; 98: 2005-2010.
10. Bruun JM, Lihn AS, Verdich C, et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003; 285: E527-E533.
11. Ouchi N, Kihara S, Arita Y, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001; 103: 1057-1063.
12. Yamaguchi N, Argueta JG, Masuhiro Y, et al. Adiponectin inhibits Toll-like receptor family-induced signaling. FEBS Lett 2005; 579: 6821-6826.
13. Bansilal S, Farkouh ME, Fuster V,. Role of insulin resistance and hyperglycemia in the development of atherosclerosis. Am J Cardiol 2007; 99: 6B-14B.
14. Jordan E, Kley S, Le NA, Waldron M, Hoenig M,. Dyslipidemia in obese cats. Domest Anim Endocrinol 2008; 35: 290-299.
15. Hoenig M, Ferguson DC,. Impairment of glucose tolerance in hyperthyroid cats. J Endocrinol 1989; 121: 249-251.
16. Kley S, Caffall Z, Tittle E, Ferguson DC, Hoenig M,. Development of a feline proinsulin immunoradiometric assay and a feline proinsulin enzyme-linked immunosorbent assay (ELISA): a novel application to examine beta cell function in cats. Domest Anim Endocrinol 2008; 34: 311-318.
17. Hoenig M, Thomaseth K, Brandao J, Waldron M, Ferguson D,. Assessment and mathematical modeling of glucose turnover and insulin sensitivity in lean and obese cats. Dom Anim Endo 2006; 31: 373-389.
18. Pinheiro J, Bates D, DebRoy S, Sarkar D,. nlme: Linear and nonlinear mixed effects models. R package version 2009; 3: 1-96.
19. Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA,. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease. Arterioscler Thromb Vasc Biol 1998; 18: 1046-1053.
20. Goff DC, Jr, D'Agostino RB, Jr, Haffner SM, Otvos JD,. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism 2005; 54: 264-270.
21. Rieusset J, Bouzakri K, Chevillotte E, et al. Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Diabetes 2004; 53: 2232-2241.
22. Jager J, Gremeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF,. Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 2007; 148: 241-251.
23. Vozarova B, Weyer C, Hanson K, Tataranni PA, Bogardus C, Pratley RE,. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001; 9: 414-417.
24. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM,. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.
25. Kellerer M, Rett K, Renn W, Groop L, Haring HU,. Circulating TNF-alpha and leptin levels in offspring of NIDDM patients do not correlate to individual insulin sensitivity. Horm Metab Res 1996; 28: 737-743.
26. Hauner H, Bender M, Haastert B, Hube F,. Plasma concentrations of soluble TNF-alpha receptors in obese subjects. Int J Obes Relat Metab Disord 1998; 22: 1239-1243.
27. Hoenig M, McGoldrick JB, deBeer M, Demacker PN, Ferguson DC,. Activity and tissue-specific expression of lipases and tumor-necrosis factor alpha in lean and obese cats. Domest Anim Endocrinol 2006; 30: 333-344.
28. Inadera H,. The usefulness of circulating adipokine levels for the assessment of obesity-related health problems. Int J Med Sci 2008; 5: 248-262.
29. Hauner H,. Secretory factors from human adipose tissue and their functional role. Proc Nutr Soc 2005; 64: 163-169.
30. Dentener MA, Louis R, Cloots RH, Henket M, Wouters EF,. Differences in local versus systemic TNFalpha production in COPD: inhibitory effect of hyaluronan on LPS induced blood cell TNFalpha release. Thorax 2006; 61: 478-484.
31. Houstis N, Rosen ED, Lander ES,. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006; 440: 944-948.
32. Jaso-Friedmann L, Leary III JH, Praveen K, Waldron M, Hoenig, M,. The effects of obesity and fatty acids on the feline immune system. J Vet Immunol Immunopathol 2008; 122: 146-152.
33. Hamdy O, Porramatikul S, Al-Ozairi E,. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006; 2: 367-373.
34. Thamer C, Machann J, Stefan N, et al. High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention. Obesity (Silver Spring) 2007; 15: 531-538.
35. Gower BA, Nagy TR, Goran MI,. Visceral fat, insulin sensitivity, and lipids in prepubertal children. Diabetes 1999; 48: 1515-1521.
36. Orr JS, Gentile CL, Davy BM, Davy KP,. Large artery stiffening with weight gain in humans: role of visceral fat accumulation. Hypertension 2008; 51: 1519-1524.
37. Shadid S, Jensen MD,. Effects of pioglitazone versus diet and exercise on metabolic health and fat distribution in upper body obesity. Diabetes Care 2003; 26: 3148-3152.
38. Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 2004; 350: 2549-2557.
39. Gohda T, Gotoh H, Tanimoto M, et al. Relationship between abdominal fat accumulation and insulin resistance in hemodialysis patients. Hypertens Res 2008; 31: 83-88.
40. Hoenig M, Caffall Z,., Ferguson DC,. Triiodothyronine differentially regulates key metabolic factors in lean and obese cats. Dom Anim Endocrinol 2008; 34: 229-237.